Any claim that spending on the PBS is stagnant belies $3.3 billion in topline growth, representing the program's single biggest year-on-year financial expansion in its 75-year history, $7 billion in new listings over 18 months, Budget rules and the impact of the industry's agreements with the federal government.
Far from 'stagnating', the PBS has delivered record growth as it rapidly approaches $20 billion
May 10, 2023 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
The Dispatched Podcast 'Week in Review' - 20 February
February 20, 2026 - - Podcast -
PhRMA launches new campaign against the backdrop of a more assertive U.S.
February 19, 2026 - - Latest News -
Why does anyone accept a review outcome that simply affirms a settled order
February 19, 2026 - - Latest News -
Wesfarmers Health emerges as growth engine after delivering strong first half
February 19, 2026 - - Australian Biotech -
Telix files for European approval of brain cancer imaging candidate TLX101-Px
February 18, 2026 - - Australian Biotech -
IDT signals turnaround as revenue rises and losses narrow under strategic reset
February 18, 2026 - - Latest News -
Nyrada advances lead candidate into mid-stage trial as momentum builds across programs
February 18, 2026 - - Australian Biotech

